PATHOPHARMACOLOGICAL
FOUNDATIONS OA 150 HIGH YIELD Q
and A WITH DETAILED RATIONALES
A+ GUARANTEE
1. A patient with a history of chronic hypertension presents
with left ventricular hypertrophy. Which cellular
adaptation best describes this pathological change? A)
Hyperplasia B) Metaplasia C) Hypertrophy. Correct
Answer: Rationale: Hypertrophy is the increase in
the size of individual cells, resulting in an enlarged organ.
In the heart, increased workload from chronic
hypertension causes cardiac myocytes to undergo
hypertrophy, unlike hyperplasia which is an increase in
cell number. D) Dysplasia
2. During an acute inflammatory response, which chemical
mediator is primarily responsible for the immediate
vasodilation and increased vascular permeability? A)
Prostaglandins B) Histamine. Correct Answer:
Rationale: Histamine is preformed in mast cells and
released immediately upon tissue injury, causing rapid
vasodilation and increased vascular permeability,
leading to the classic signs of redness and swelling. C)
Leukotrienes D) Bradykinin
3. A patient experiences an anaphylactic reaction after a bee
sting. This is an example of which type of hypersensitivity
reaction? A) Type I. Correct Answer: Rationale:
Type I hypersensitivity is an IgE-mediated immediate
reaction where allergens cross-link IgE on mast cells,
, causing degranulation and release of histamine, leading
to anaphylaxis. B) Type II C) Type III D) Type IV
4. A nurse practitioner prescribes an oral medication that
undergoes extensive first-pass metabolism in the liver.
What is the primary pharmacokinetic implication for this
patient? A) The drug will have a longer half-life. B) A
significantly higher oral dose is required compared to the
intravenous dose to achieve the same systemic effect.
Correct Answer: Rationale: First-pass
metabolism refers to the rapid hepatic inactivation of
oral drugs before they reach systemic circulation.
Consequently, a much larger oral dose is needed to
achieve the same bioavailability as an IV dose. C) The
drug will be excreted more rapidly by the kidneys. D) The
drug will have increased protein binding in the plasma.
5. Which of the following best describes the mechanism of
action of a competitive receptor antagonist? A) It binds to
the receptor and produces a maximal cellular response. B)
It binds to the receptor but does not activate it, preventing
the endogenous agonist from binding. Correct
Answer: Rationale: Competitive antagonists have
affinity for the receptor but zero intrinsic activity. They
block the binding of agonists, and their effects can be
overcome by increasing the concentration of the agonist.
C) It binds to an allosteric site and changes the receptor's
conformation to enhance agonist binding. D) It
irreversibly binds to the receptor, permanently destroying
its function.
6. A patient with osteoarthritis is prescribed a nonselective
NSAID. Which adverse effect is directly related to the
inhibition of the COX-1 enzyme? A) Reduced
inflammation B) Gastric mucosal ulceration. Correct
, Answer: Rationale: COX-1 is constitutively expressed
in the gastric mucosa and produces prostaglandins that
protect the stomach lining by inhibiting acid secretion
and promoting mucus production. Inhibition of COX-1 by
nonselective NSAIDs removes this protection, leading to
ulcers. C) Analgesia D) Antipyresis
7. A patient has been on high-dose systemic corticosteroids
for several months. What is the most critical education
regarding the discontinuation of this medication? A) It can
be stopped abruptly without any consequences. B) The
dose must be tapered gradually to prevent adrenal crisis
due to hypothalamic-pituitary-adrenal (HPA) axis
suppression. Correct Answer: Rationale:
Exogenous corticosteroids suppress the HPA axis, leading
to decreased endogenous cortisol production. Abrupt
cessation can precipitate a life-threatening adrenal
crisis; therefore, a gradual taper is required to allow the
adrenal glands to recover. C) The patient should double
the dose for the last week of therapy. D) The medication
should be switched to an inhaled corticosteroid
immediately.
8. A patient presents to the emergency department with
acetaminophen toxicity. Which toxic metabolite is
primarily responsible for hepatic necrosis, and what is its
specific antidote? A) NAPQI; N-acetylcysteine. Correct
Answer: Rationale: Acetaminophen is metabolized
by CYP450 enzymes into the highly toxic metabolite
NAPQI. Normally, NAPQI is conjugated with glutathione.
In overdose, glutathione is depleted, and NAPQI causes
hepatocellular death. N-acetylcysteine acts as a
glutathione precursor and antidote. B) Acetic acid;
Flumazenil C) Benzoylecgonine; Naloxone D) Morphine-
6-glucuronide; Activated charcoal
, 9. Opioid analgesics can cause life-threatening respiratory
depression. This adverse effect is primarily mediated
through agonism at which receptor location? A) Mu
receptors in the spinal cord dorsal horn. B) Mu receptors
in the brainstem respiratory center. Correct Answer:
Rationale: While mu receptor agonism in the spinal
cord mediates analgesia, agonism at mu receptors in the
medullary respiratory center decreases the brainstem's
sensitivity to carbon dioxide, leading to respiratory
depression. C) Kappa receptors in the limbic system. D)
Delta receptors in the gastrointestinal tract.
10. In the pathophysiology of heart failure, the activation
of the renin-angiotensin-aldosterone system (RAAS)
initially serves as a compensatory mechanism. What is the
long-term pathological consequence of this chronic
activation? A) Decreased cardiac preload and afterload. B)
Increased myocardial oxygen consumption, ventricular
remodeling, and fluid retention. Correct Answer:
Rationale: While RAAS activation initially maintains
blood pressure and perfusion, chronic activation leads to
sodium and water retention (increasing preload),
vasoconstriction (increasing afterload), and maladaptive
cardiac remodeling, ultimately worsening heart failure.
C) Downregulation of beta-adrenergic receptors. D)
Increased renal blood flow and glomerular filtration rate.
11. A patient developed a persistent, dry cough after
starting a new antihypertensive medication. Which class of
drugs is most likely responsible, and what is the
underlying mechanism? A) Beta-blockers;
bronchoconstriction. B) ACE inhibitors; accumulation of
bradykinin. Correct Answer: Rationale: ACE
inhibitors block the angiotensin-converting enzyme,
which is also responsible for the breakdown of